Fundraising FoxZxerex
Scottsdale, US · Founded 2016 · Delaware corporation
Find your way into Zxerex
Sign up to see every warm intro you have to Zxerex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zxerex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZXEREX develops a science-based impairment screening technology, enhanced with AI and machine learning, that detects temporary neurologic impairment from drugs, alcohol, or fatigue by measuring the drug's effects on the brain rather than its presence in the body. Its products ZXEREX-Safe and Impair-ID offer non-invasive, fast (2-3 minute) impairment tests aimed at workplace safety programs to reduce accidents and injuries.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 2 rounds · 2017–2019
▶$50KraisedOct 2019 · 1 investors · Other TechnologyRule 506(b)
- Richard BessermanExecutive Officer, Director
- Mike EffingerExecutive Officer
- Gregory SchwimerExecutive Officer
- Julie DaleDirector
- Offering amount
- $500K
- Amount sold
- $50K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.4MraisedDec 2017 · 6 investors · Other TechnologyRule 506(b)
- MARK K. ATTINGERExecutive Officer, Director
- RICHARD DALEExecutive Officer, Director
- RICHARD BESSERMANExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.4M
- Minimum investment
- $120K
- Proceeds to insiders
- $800K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Zxerex do?
- ZXEREX develops a science-based impairment screening technology, enhanced with AI and machine learning, that detects temporary neurologic impairment from drugs, alcohol, or fatigue by measuring the drug's effects on the brain rather than its presence in the body. Its products ZXEREX-Safe and Impair-ID offer non-invasive, fast (2-3 minute) impairment tests aimed at workplace safety programs to reduce accidents and injuries.
- How much funding has Zxerex raised?
- Zxerex has disclosed $1.4M raised across 2 rounds.
- Where is Zxerex headquartered?
- Zxerex is headquartered in Scottsdale, US.